US2012252030A1PendingUtilityA1
5-bromo-2'-deoxy-uridine labeled nucleotide triphosphates and nucleic acid probes and methods of making and using the same
Est. expiryJun 14, 2027(~0.9 yrs left)· nominal 20-yr term from priority
C07H 21/00
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
5-bromo-2′-deoxy-uridine (BrdU) labeled nucleotide triphosphates and nucleic acid probes are described herein. The BrdU labeled nucleotide triphosphates include a linker between the nucleotide triphosphate and the BrdU moiety. The linker can be cleavable or non-cleavable. The nucleotide triphosphates can be a ribonucleotide triphosphates, 2′-deoxyribonucleotide triphosphates or 2′,3′-dideoxyribonucleotide triphosphates. The nucleic acid probes can be used for in situ hybridization.
Claims
exact text as granted — not AI-modified1 . A compound of the formula:
or a salt thereof, wherein “Nu” is a nucleotide triphosphate, a 2′-deoxynucleotide triphosphate or a 2′,3′-dideoxynucleotide triphosphate and wherein L is a linker.
2 . The compound of claim 1 , wherein L has a length greater than a C 11 n-alkane carbon chain.
3 . The compound of claim 1 , wherein “Nu” is uridine triphosphate, 2′-deoxyuridine triphosphate or 2′,3′-dideoxytriphosphate.
4 . The compound of claim 1 , wherein the compound is of the formula:
or a salt thereof, wherein each X is independently H or OH and “L” is a linker.
5 . The compound of claim 1 , wherein “L” is a linker having a chemical structure selected from the group consisting of:
wherein n is an integer of from 6 to 12.
6 . A sodium salt of the compound of claim 1 .
7 . The compound of claim 1 , wherein the compound is of the formula:
or a salt thereof, wherein each X is independently H or OH.
8 . A sodium salt of the compound of claim 7 .
9 . A polynucleotide represented by the formula:
wherein “Y” is a nucleoside, a nucleotide or a polynucleotide, “Z” is H, a nucleotide or a polynucleotide, “X” is H or OH, “B” is a nucleobase and “L” is a linker.
10 . The polynucleotide of claim 9 , wherein the polynucleotide is represented by the formula:
wherein “Y” is a nucleoside, nucleotide or polynucleotide, “Z” is H, a nucleotide or a polynucleotide, “X” is H or OH and “L” is a linker.
11 . The polynucleotide of claim 9 , wherein “L” is a linker having a chemical structure selected from the group consisting of:
wherein n is an integer of from 6 to 12.
12 . (canceled)
13 . A method for detecting the presence of a nucleic acid analyte in a tissue sample comprising:
incubating the tissue sample with a composition comprising the polynucleotide of claim 9 , wherein the polynucleotide binds to the nucleic acid analyte; washing the sample; contacting the sample with an anti-BrdU antibody conjugated to a detectable moiety or to an enzyme; and detecting the detectable moiety or enzyme.
14 . The method of claim 13 , further comprising fixing the sample prior to incubating the sample.
15 . The method of claim 14 , wherein fixing comprises contacting the sample with an acid or a cross-linking agent.
16 . A composition comprising:
adenosine triphosphate (ATP); uridine triphosphate (UTP); guanosine triphosphate (GTP); cytidine triphosphate (CTP); and a compound as set forth in claim 1 , wherein “Nu” is a nucleotide triphosphate.
17 - 25 . (canceled)Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.